메뉴 건너뛰기




Volumn 39, Issue 216, 2005, Pages 8-19

Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives

(12)  Srigley, John R a,l   Amin, Mahul b   Boccon Gibod, Liliane c   Egevad, Lars d   Epstein, Jonathan I e   Humphrey, Peter A f   Mikuz, Gregor g   Newling, Don h   Nilsson, Sten d   Sakr, Wael i   Wheeler, Thomas M j   Montironi, Rodolfo k  


Author keywords

Historical aspects; Prediction; Previous consensus initiatives; Prognostic factors; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; TUMOR MARKER;

EID: 22144463914     PISSN: 03008886     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008880510030914     Document Type: Conference Paper
Times cited : (47)

References (51)
  • 2
    • 0141858282 scopus 로고    scopus 로고
    • Prognostic factors: Principles and application
    • Gospodarowicz MK, Henson, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind Ch, editors. New York: Wiley-Liss
    • Gospodarowicz MK, O'Sullivan B. Prognostic factors: principles and application. In: Gospodarowicz MK, Henson, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind Ch, editors. Prognostic factors in cancer, 2nd ed. New York: Wiley-Liss; 2001. p. 17-35.
    • (2001) Prognostic Factors in Cancer, 2nd Ed. , pp. 17-35
    • Gospodarowicz, M.K.1    O'Sullivan, B.2
  • 3
    • 0028070813 scopus 로고
    • Increasing the power of surrogate endpoint biomarkers: The aggregation of predictive factors
    • Burke HB. Increasing the power of surrogate endpoint biomarkers: the aggregation of predictive factors. J Cell Biochem Suppl 1994;19:278-82.
    • (1994) J Cell Biochem Suppl , vol.19 , pp. 278-282
    • Burke, H.B.1
  • 4
    • 0027235762 scopus 로고
    • Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients
    • Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 1993;85:1206-19.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 1206-1219
    • Gasparini, G.1    Pozza, F.2    Harris, A.L.3
  • 5
    • 0032412818 scopus 로고    scopus 로고
    • The relationship between prognostic and predictive factors in the management of breast cancer
    • Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 1998;52:261-88.
    • (1998) Breast Cancer Res Treat , vol.52 , pp. 261-288
    • Henderson, I.C.1    Patek, A.J.2
  • 6
    • 0003276406 scopus 로고
    • Tumors of the male sex organs
    • series 1, fascicle 32. Washington D.C.: Armed Forces Institute of Pathology
    • Dixon FJ, Moore RA. Tumors of the male sex organs. Atlas of tumor pathology, series 1, fascicle 32. Washington D.C.: Armed Forces Institute of Pathology; 1952. p. 10.
    • (1952) Atlas of Tumor Pathology , pp. 10
    • Dixon, F.J.1    Moore, R.A.2
  • 7
    • 22144438214 scopus 로고
    • Hormone therapy and prostate cancer
    • Whitmore WF Jr. Hormone therapy and prostate cancer. Am J Med 1956;697:613.
    • (1956) Am J Med , vol.697 , pp. 613
    • Whitmore Jr., W.F.1
  • 8
    • 0016466084 scopus 로고
    • The present status of radical prostatectomy for stage a and B prostate cancer
    • Jewett HJ. The present status of radical prostatectomy for stage A and B prostate cancer. Urol Clin North Am 1975;2:105-24.
    • (1975) Urol Clin North Am , vol.2 , pp. 105-124
    • Jewett, H.J.1
  • 10
    • 84900367176 scopus 로고
    • Squamous cell epithelioma of the lip
    • Broders AC. Squamous cell epithelioma of the lip. JAMA 1920;74:656-64.
    • (1920) JAMA , vol.74 , pp. 656-664
    • Broders, A.C.1
  • 12
    • 0038541172 scopus 로고
    • Carcinoma of the prostate
    • Muir EG. Carcinoma of the prostate. Lancet 1934;i:667-72.
    • (1934) Lancet , vol.1 , pp. 667-672
    • Muir, E.G.1
  • 14
    • 0016608092 scopus 로고
    • Grading of prostate carcinoma
    • Mostofi FK. Grading of prostate carcinoma. Cancer Chemother Rep 1975;59:111-7.
    • (1975) Cancer Chemother Rep , vol.59 , pp. 111-117
    • Mostofi, F.K.1
  • 16
    • 0013890366 scopus 로고
    • Classification of prostatic carcinoma
    • Gleason DF. Classification of prostatic carcinoma. Cancer Chemother Rep 1966;50:125-8.
    • (1966) Cancer Chemother Rep , vol.50 , pp. 125-128
    • Gleason, D.F.1
  • 17
    • 0014051456 scopus 로고
    • The histology and prognosis of prostatic cancer
    • Mellinger GT, Gleason D, Bailar J III. The histology and prognosis of prostatic cancer. J Urol 1967;97:331-7.
    • (1967) J Urol , vol.97 , pp. 331-337
    • Mellinger, G.T.1    Gleason, D.2    Bailar III, J.3
  • 18
    • 0001916430 scopus 로고
    • Histologic grading and clinical staging of prostatic carcinoma
    • Tannenbaum M, editor. Philadelphia, PA: Lea & Febiger
    • Gleason DF, Veterans Administration Cooperative Urological Research Group. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology: the prostate. Philadelphia, PA: Lea & Febiger; 1977. p. 171-97.
    • (1977) Urologic Pathology: The Prostate , pp. 171-197
    • Gleason, D.F.1
  • 19
    • 0001625949 scopus 로고    scopus 로고
    • Tumors of the prostate gland, seminal vesicles, male urethra, and penis
    • 3rd series, fascicle 28. Washington D.C.: American Registry of Pathology
    • Young RH, Srigley JR, Amin MB, et al. Tumors of the prostate gland, seminal vesicles, male urethra, and penis. Atlas of tumor pathology, 3rd series, fascicle 28. Washington D.C.: American Registry of Pathology; 2000.
    • (2000) Atlas of Tumor Pathology
    • Young, R.H.1    Srigley, J.R.2    Amin, M.B.3
  • 20
    • 17644397285 scopus 로고    scopus 로고
    • Pathology and genetics. Tumors of the urinary system and male genital organs
    • Lyon, France: IARC Press
    • Eble JN, Sauter G, Epstein JI, et al. Pathology and genetics. Tumors of the urinary system and male genital organs. WHO classification of tumors. Lyon, France: IARC Press; 2004.
    • (2004) WHO Classification of Tumors
    • Eble, J.N.1    Sauter, G.2    Epstein, J.I.3
  • 21
    • 0033859846 scopus 로고    scopus 로고
    • Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: A basis for checklists
    • Srigley JR, Amin MB, Bostwick DG, et al. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Arch Pathol Lab Med 2000;124:1034-9.
    • (2000) Arch Pathol Lab Med , vol.124 , pp. 1034-1039
    • Srigley, J.R.1    Amin, M.B.2    Bostwick, D.G.3
  • 23
    • 0026548628 scopus 로고
    • Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment
    • Fossa SD, Paus E, Lindegaard M, et al. Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment. Br J Urol 1992;69:175-9.
    • (1992) Br J Urol , vol.69 , pp. 175-179
    • Fossa, S.D.1    Paus, E.2    Lindegaard, M.3
  • 24
    • 0028153027 scopus 로고
    • Prognostic factors in stage D2 prostate cancer; important implications for future trials: Results of a cooperative intergroup study (INT.0036)
    • The National Cancer Institute Intergroup Study #0036
    • Eisenberger MA, Crawford ED, Wolf M, et al. Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036. Semin Oncol 1994;21:613-9.
    • (1994) Semin Oncol , vol.21 , pp. 613-619
    • Eisenberger, M.A.1    Crawford, E.D.2    Wolf, M.3
  • 25
    • 0030926567 scopus 로고    scopus 로고
    • Prognostic significance of prostate-specific antigen in stage Tie prostate cancer treated by radical prostatectomy
    • Cookson MS, Fleshner NE, Soloway SM, et al. Prognostic significance of prostate-specific antigen in stage Tie prostate cancer treated by radical prostatectomy. Urology 1997;49:887-97.
    • (1997) Urology , vol.49 , pp. 887-897
    • Cookson, M.S.1    Fleshner, N.E.2    Soloway, S.M.3
  • 26
    • 0030907162 scopus 로고    scopus 로고
    • Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: The basis for an adjuvant therapy trial
    • D'Amico AV, Whittington R, Malkowicz SB, et al. Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 1997;15:1465-9.
    • (1997) J Clin Oncol , vol.15 , pp. 1465-1469
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 27
    • 0030913315 scopus 로고    scopus 로고
    • Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer
    • Partin AW, Nathan MW, Subong ENP. Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997;277:145-51.
    • (1997) JAMA , vol.277 , pp. 145-151
    • Partin, A.W.1    Nathan, M.W.2    Subong, E.N.P.3
  • 28
    • 0030906817 scopus 로고    scopus 로고
    • Consensus statement: Guidelines for PSA following radiation therapy
    • American Society of Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-41.
    • (1997) Int J Radiat Oncol Biol Phys , vol.37 , pp. 1035-1041
  • 29
    • 0032839364 scopus 로고    scopus 로고
    • PSA-based outcome analysis after radiation therapy for prostate cancer: A new definition of biochemical failure after intervention
    • Jani AB, Chen MH, Vaida F, et al. PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention. Urology 1999;554:700-5.
    • (1999) Urology , vol.554 , pp. 700-705
    • Jani, A.B.1    Chen, M.H.2    Vaida, F.3
  • 30
    • 0033253970 scopus 로고    scopus 로고
    • Post-treatment PSA ≤0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques
    • Critz FA, Williams WH, Holladay CT, et al. Post-treatment PSA ≤0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques. Urology 1999;54:968-71.
    • (1999) Urology , vol.54 , pp. 968-971
    • Critz, F.A.1    Williams, W.H.2    Holladay, C.T.3
  • 31
    • 0032774409 scopus 로고    scopus 로고
    • PSA decline is an independent prognostic marker in hormonally treated prostate cancer
    • Palmberg C, Koivisto P, Visakorpi T, et al. PSA decline is an independent prognostic marker in hormonally treated prostate cancer. Eur Urol 1999;36:191-6.
    • (1999) Eur Urol , vol.36 , pp. 191-196
    • Palmberg, C.1    Koivisto, P.2    Visakorpi, T.3
  • 32
    • 0028324389 scopus 로고    scopus 로고
    • Early androgen ablation for stage D1 (N1T0N3,M0) prostate cancer: Prognostic variable and outcome
    • Zagars GK, Sands ME, Pollack A, et al. Early androgen ablation for stage D1 (N1T0N3,M0) prostate cancer: prognostic variable and outcome. J Urol 1999;151:1330-3.
    • (1999) J Urol , vol.151 , pp. 1330-1333
    • Zagars, G.K.1    Sands, M.E.2    Pollack, A.3
  • 33
    • 0033451682 scopus 로고    scopus 로고
    • Predictive factors in prostate cancer: Current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer
    • Bostwick DG, Foster CS. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin Urol Oncol 1999;17:222-72.
    • (1999) Semin Urol Oncol , vol.17 , pp. 222-272
    • Bostwick, D.G.1    Foster, C.S.2
  • 34
    • 12944332009 scopus 로고    scopus 로고
    • Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999
    • Bostwick DG, Grignon DG, Hammond EH, et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:995-1000.
    • (2000) Arch Pathol Lab Med , vol.124 , pp. 995-1000
    • Bostwick, D.G.1    Grignon, D.G.2    Hammond, E.H.3
  • 35
    • 0015950349 scopus 로고
    • The Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging
    • Gleason DF, Mellinger GT. The Veterans Administration Cooperative Urological Research Group: prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
    • (1974) J Urol , vol.111 , pp. 58-64
    • Gleason, D.F.1    Mellinger, G.T.2
  • 36
    • 0027362788 scopus 로고
    • Criteria for prognostic factors and for an enhanced prognostic system
    • Burke HB, Henson DE. Criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-5.
    • (1993) Cancer , vol.72 , pp. 3131-3135
    • Burke, H.B.1    Henson, D.E.2
  • 37
    • 22144441251 scopus 로고    scopus 로고
    • Statistical methods for the analysis of prognostic factor studies
    • Gospodarowicz MK, Hensen DE, Hutter REP, et al., editors. New York: Wiley-Liss
    • McShane LM, Simon R. Statistical methods for the analysis of prognostic factor studies. In: Gospodarowicz MK, Hensen DE, Hutter REP, et al., editors. Prognostic factors in cancer, 2nd ed. New York: Wiley-Liss; 2001. p. 49-56.
    • (2001) Prognostic Factors in Cancer, 2nd Ed. , pp. 49-56
    • McShane, L.M.1    Simon, R.2
  • 38
    • 0034287457 scopus 로고    scopus 로고
    • Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
    • Kattan MW, Zelefsky MJ, Kupelian PA, et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 2000;18:3352-9.
    • (2000) J Clin Oncol , vol.18 , pp. 3352-3359
    • Kattan, M.W.1    Zelefsky, M.J.2    Kupelian, P.A.3
  • 39
    • 0034872990 scopus 로고    scopus 로고
    • Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer
    • Kattan MW, Potters L, Blasko JC, et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 2001;58:393-9.
    • (2001) Urology , vol.58 , pp. 393-399
    • Kattan, M.W.1    Potters, L.2    Blasko, J.C.3
  • 40
    • 0032550753 scopus 로고    scopus 로고
    • A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
    • Kattan MW, Eastham JA, Stapleton AMF, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766-71.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 766-771
    • Kattan, M.W.1    Eastham, J.A.2    Stapleton, A.M.F.3
  • 41
    • 0031047117 scopus 로고    scopus 로고
    • Artificial neural networks improve the accuracy of cancer survival prediction
    • Burke HB, Goodman PH, Rosen DB, et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997;79:857-62.
    • (1997) Cancer , vol.79 , pp. 857-862
    • Burke, H.B.1    Goodman, P.H.2    Rosen, D.B.3
  • 42
    • 22144435072 scopus 로고
    • Diagnosis and prognostic parameters in localized prostate cancer
    • Diagnosis and prognostic parameters in localized prostate cancer. Scand J Urol Nephrol Suppl 1994;162:1-127.
    • (1994) Scand J Urol Nephrol Suppl , vol.162 , pp. 1-127
  • 43
    • 0029562716 scopus 로고
    • College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors
    • Henson DE, Fielding LP, Grignon DJ, et al. College of American Pathologists Conference XXVI on Clinical Relevance of Prognostic Markers in Solid Tumors. Arch Pathol Lab Med 1995;119:1109-12.
    • (1995) Arch Pathol Lab Med , vol.119 , pp. 1109-1112
    • Henson, D.E.1    Fielding, L.P.2    Grignon, D.J.3
  • 44
    • 0029617845 scopus 로고
    • College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors
    • Grignon DJ, Hammond EH. College of American Pathologists Conference XXVI on Clinical Relevance of Prognostic Markers in Solid Tumors. Arch Pathol Lab Med 1995;119:1122-6.
    • (1995) Arch Pathol Lab Med , vol.119 , pp. 1122-1126
    • Grignon, D.J.1    Hammond, E.H.2
  • 45
    • 0033854631 scopus 로고    scopus 로고
    • College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what?
    • Hammond ME, Fitzgibbons PL, Compton CC, et al. College of American Pathologists Conference XXXV: Solid Tumor Prognostic Factors - Which, How and So What? Arch Pathol Lab Med 2000;124:958-65.
    • (2000) Arch Pathol Lab Med , vol.124 , pp. 958-965
    • Hammond, M.E.1    Fitzgibbons, P.L.2    Compton, C.C.3
  • 46
    • 0030036589 scopus 로고    scopus 로고
    • Current prognostic factors for prostate carcinoma
    • Montie JE. Current prognostic factors for prostate carcinoma. Cancer 1996;78:341-4.
    • (1996) Cancer , vol.78 , pp. 341-344
    • Montie, J.E.1
  • 47
    • 0029683042 scopus 로고    scopus 로고
    • Current prognostic factors and their relevance to staging
    • Hutter RVP, Montie JE, Busch D, et al. Current prognostic factors and their relevance to staging. Cancer 1996;78:369-71.
    • (1996) Cancer , vol.78 , pp. 369-371
    • Hutter, R.V.P.1    Montie, J.E.2    Busch, D.3
  • 48
    • 0030036082 scopus 로고    scopus 로고
    • Exploration of new pathologic factors in terms of potential for prognostic significance and future applications
    • Von Eschenbach AC, Brawer MK, di Sant'Agnese A, et al. Exploration of new pathologic factors in terms of potential for prognostic significance and future applications. Cancer 1996;78:372-5.
    • (1996) Cancer , vol.78 , pp. 372-375
    • Von Eschenbach, A.C.1    Brawer, M.K.2    Di Sant'Agnese, A.3
  • 51
    • 5444263006 scopus 로고    scopus 로고
    • Evidence-based medicine, medical decision analysis, and pathology
    • Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol 2004;35:1179-88.
    • (2004) Hum Pathol , vol.35 , pp. 1179-1188
    • Marchevsky, A.M.1    Wick, M.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.